Smith & Nephew and OrthoSensor to co-market orthopedic surgical tech and tools

Smith & Nephew ($SNN) has inked a co-marketing deal with OrthoSensor involving one of the company's orthopedic surgical tools. Neither side is discussing financial details. But the deal allows joint marketing of OrthoSensor's Verasense sensor-assisted surgery tech for soft tissue balancing with Smith & Nephew's Journey II and Legion total knee replacement systems. U.K.-based Smith & Nephew gains added selling points with the joint deal, and Florida-based OrthoSensor once again gets to reach a larger audience through a partnership with a global company. Last November, OrthoSensor sealed a co-marketing deal with Zimmer ($ZMH) that allowed Zimmer's knee systems to be marketed with Verasense, which uses sensors to wirelessly transmit data to surgeons so they can achieve a more balanced knee implant fit. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.